Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD

Journal of Pharmaceutical and Biomedical Analysis

Volumn 25, Issue 5-6, 2001, Pages 741-750

  Agatonovic Kustrin, S ^a   Rades, T ^b   Wu, V ^b   Saville, D ^b   Tucker, I G ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Crystal; Polymorphs; Ranitidine

Indexed keywords

ANTIULCER AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ANALYTIC METHOD; ARTICLE; ARTIFICIAL NEURAL NETWORK; CRYSTAL; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG DETERMINATION; DRUG STRUCTURE; GEOMETRY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RACEMIC MIXTURE; SOLID STATE; SPECTROPHOTOMETER; X RAY POWDER DIFFRACTION;

RANITIDINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 0035017293     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(01)00375-2     Document Type: Article

References (38)

1. S.R. Byrn, in: Solid State Chemistry of Drugs, Academic Press, New York, 1982, pp. 7, 140-146, 332.
2. Byrn S., Pfeiffer R., Ganey M., Hoiberg C., Poochikian G. Pharmaceutical solids - a strategic approach to regulatory consideration. Pharm. Res. 12:1995;945-954.
3. Borka L. Reviw on crystal polymorphism of substances in the European Pharmacopeia. Pharm. Acta Helv. 66:1991;16-22.
4. Threlfall T.L. Analysis of organic polymorphs-a review. Analyst. 120:1995;2435-2460.
5. Madan T., Kakkar A.P. Preparation and characterization of ranitidine-HCl crystals. Drug Dev. Ind. Pharm. 20:1994;1571-1588.
6. Hohnjek M., Kuftinec J., Malnar M., Skreblin M., Kajfez N.A., Blazevic N. Ranitidine. Analytical Profiles of Drug Substances. 15:1986;534-561 Academic Press, New York.
7. Crookes D.L. Crystalline ranitidine hydrochloride and pharmaceutical composition containing it. Chem. Abs. 97:1982;332.
8. D.L. Crookes, UK Pat. 2084580B, 1982.
9. Shen J., Lee D., Mckeag R.G. Bioequivalence of two forms of ranitidine. NZ Pharmacy. 15:1995;24-25.
10. Bawazir S.A., Gouda M.W., El-Sayed Y.M. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Int. J. Clin. Pharm. 36:1998;270-274.
11. Carstensen J.T., Franchini M.K. Isoenergic polymorphs. Drug Dev. Ind. Pharm. 21:1995;523-536.
12. Foster A., Gordon K., Schmirer D., Soper N., Wu V., Rades T. Characterisation of two polymorphic forms of ranitidine-HCl. Int. J. Vibrational Spectrosc. 2:1998;. Ed. 2:12.
13. Olmos P., Diaz J.C., Perez J.M., Gomez P. A new approach to automatic radiation spectrum analysis. IEEE Trans. Nucl. Sci. 38:1991;971-975.
14. Hobert H., Meyer K. Infrared spectroscopic analysis of complex mixtures by classification and regression. Fresenius J. Anal. Chem. 344:1992;178-185.
15. Tanabe K., Tamura T., Uesaka H. Neural network system for the identification of infrared spectra. Appl. Spectrosc. 46:1992;807-810.
16. Shadmehr R., Angell D., Chou P.B., Oehrlein G.S., Jaffe R.S. Principal component analysis of optical emission spectroscopy and mass spectrometry: application to reactive ion etch process parameter estimation using neural networks. J. Electrochem. Soc. 139:1992;907-914.
17. Meyer B., Hansen T., Nute D., Albersheim P., Darvill A., York W., Sellers J. Identification of the H-1-NMR spectra of complex oligosaccharides with artificial neural networks. Science. 251:1991;542-544.
18. Amendolia S.R., Doppiu A., Ganadu M.L., Lubinu G. Classification and quantitation of H-1 NMR spectra of alditols binary mixtures using artificial neural networks. Anal. Chem. 70:1998;1249-1254.
19. Bos M., Weber H.T. Comparison of the training of neural networks for quantitative X-ray fluorescence spectrometry by a genetic algorithm and backward error propagation. Anal. Chim. Acta. 247:1991;97-105.
20. Fuller M.P., Griffiths P.R. Diffuse reflectance measurements by infrared Fourier transform spectrometry. Anal. Chem. 50:1978;1906-1910.
21. Otsuka M., Kaneniwa N.J. Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding. J. Pharm. Sci. 75:1986;506-511.
22. Drablos F. Transformation for mass spectra. Anal. Chim. Acta. 256:1992;134-151.
23. White H. Artificial Neural Networks: Aproximation and Learning Theory. 1992;Blackwell, Oxford, UK.
24. Chao R.S., Vail K.C. Polymorphism of 1,2-dihydro-6-neopentyl-2-oxonicotinic acid: characterization, interconversion, and quantitation. Pharm. Res. 4:1987;429-432.
25. Ashizawa K., Uchikawa K., Hattori T., Ishibashi Y., Sato T., Miyake Y. Pseudopolymorphism and phase stability in four solid forms of (6R,7R)-7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-(Z)-2-methoxy-iminoacetamid]-3-[(4- carbamoyl-1-quinuclidinio)methyl]-8-oxo-5-thia-1-azabicyclo-[4,2,0]oct-2-ene-2- carboxylate (E1040). J. Pharm. Sci. 78:1989;893-899.
26. Cavatur R.K., Suryanarayanan R. Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry. Pharm. Dev. Technol. 3:1998;579-586.
27. US Pharmacopeia, XXIII, US Pharmacopeial Conversion, Rockville, MD, 1994, pp.107, 241, 266, 1277,1521.
28. Dreassi E., Ceramelli G., Corti P., Perruccio P.L., Lonardi S. Application of near-infrared reflectance spectrometry to the analytical control of pharmaceuticals: ranitidine hydrochloride tablet production. Analyst. 121:1996;219-222.
29. Dreassi E., Ceramelli G., Perruccio P.L., Corti P. Transfer of calibration in near-infrared reflectance spectrometry. Analyst. 123:1998;1259-1264.
30. Dreassi E., Ceramelli G., Corti P., Massacesi M., Perrucio L. Quantitative Fourier transform near-infrared spectroscopy in the quality control of solid pharmaceutical formulations. Analyst. 120:1995;2361-2365.
31. Findlay W.P., Bugay D.E. Utilization of Fourier transform Raman spectroscopy for the study of pharmaceutical crystal forms. J. Pharm. Biomed. Anal. 16:1998;921-930.
32. Potts W.F. Chemical Infrared Spectroscopy. 1:1963;Wiley, New York.
33. White R.G. Handbook of Industrial Infrared Analysis. 1967;Plenum, New York.
34. Krishnan K., Ferraro J.R. Ferraro J.R., Basile L.J. Fourier Transform Infrared Spectroscopy. 3:1982;149 Academic Press, New York.
35. Mirabella F.M. Internal Reflectance Spectroscopy. 1992;Marcel Dekker, New York.
36. Roston D.A., Walters M.C., Rhinebarger R.R., Ferro L.J. Characterization of polymorphs of a new antiinflammatory drug. J. Pharm. Biomed. Anal. 11:1993;293-300.
37. Agatonovic-Kustrin S., Tucker I.J., Schmierer D. Solid state assay of ranitidine hydrochloride as a bulk drug and as active ingredient in tablets using DRIFT spectroscopy with ANNs. Pharm. Res. 16:1999;1479-1484.
38. Robinson K.A. Chemical Analysis. 1986;754-758 Little, Brown and Company, Boston.